Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Pharma
Biogen bets HD Spinraza can outmuscle Roche's oral rival
Biogen recorded declining sales for Spinraza throughout 2025 but sees positive signs with the launch of its high-dose version of the drug in Japan.
Kevin Dunleavy
Feb 6, 2026 12:02pm
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Nov 17, 2025 11:12am
Biogen ticks up sales outlook again as MS franchise holds strong
Oct 30, 2025 1:37pm
Genentech awarded $124M in Cabilly patent dispute with Biogen
Oct 6, 2025 3:37pm
Biogen-backed web series gets Bill Nye back in the lab
Sep 30, 2025 9:45am
Biogen undeterred after FDA snub for high-dose Spinraza in SMA
Sep 24, 2025 9:51am
